PD-L1 is a glycoprotein, expressed by both cancer cells and stromal immune cells in the tumor, that engages the programmed cell death 1 (PD-1) receptor expressed on the surface of infiltrating cytotoxic T cells (CTLs)[19]. Here, CD274 is linked to cancer.